News
Recent Headlines
September 9, 2026
Bionova Scientific and Minaris Announce Partnership to Accelerate Plasmid DNA Supply for Cell and Gene Therapy Manufacturing
February 4, 2026
Scarab Genomics and Bionova Enter Exclusive Licensing Partnership to Advance High-Efficiency Plasmid DNA Production
January 8, 2026
Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies
July 3, 2025
Redefining Quality Culture at Bionova: A New Chapter Begins
May 7, 2025
Bionova Scientific Licenses ATUM’s Proprietary Transposon-Based Gene Delivery Technology to Accelerate & De-Risk Cell Line Development
March 20, 2025
Bionova Appoints Bionique Testing Laboratories as Preferred Provider for Mycoplasma Testing Services for Biologics Manufacturing
February 25, 2025
Bionova R&D Leaders Featured in Contract Pharma Q&A
January 27, 2025
Bionova’s CSO Jesse McCool Interviewed at ATW 2025
June 3, 2024
Bionova Scientific announces plans for new Plasmid DNA GMP facility
March 10, 2024
Webinar — Unlocking Efficiency: Strategies for Expedited Biotherapeutic Development
February 28, 2024
Bionova welcomes Carolina Valoyes and George Scott to leadership team
February 1, 2023
Bionova Scientific initiates expansion project to quadruple GMP biologics manufacturing capacity
January 18, 2023
Bionova Scientific introduces James Glover, II as Chief Operating Officer
July 18, 2022
Bionova Featured in BioProcess Online Article on Biopharma Resiliency
June 10, 2022
Cytiva features Bionova Scientific in Biopharma Resiliency Video Series
June 1, 2022
Asahi Kasei Medical Completes Acquisition of Bionova Scientific, U.S.-based biopharmaceutical CDMO
